Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
MONDAY, June 8, 2026 (HealthDay News) -- Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with reduced risks for thromboembolic events, emergency department use, and mortality among adults with obesity and autoimmune diseases (AIDs), according to a study published online June 6 in the Journal of the American Heart Association to coincide with the annual meeting of the American Diabetes Association, held from June 5 to 8 in New Orleans.Hao Dai, Ph.D., from the Indiana University School of Medicine in Indianapolis, and colleagues conducted a retrospective cohort study, which emulated a target trial using 2014 to 2024 electronic health record data to examine the association between GLP-1 RA use and major adverse cardiovascular and thromboembolic event risk among adults with obesity and AID
Can Mounjaro cause long-term effects
Position 34 lysine is replaced with arginine, freeing the original Lys-26 position to serve as the unique site for fatty-acid attachment
Advanced glycation end products in foods and a practical guide to their reduction in the diet
/product/99/7475523/1.jpg?7369)
US$ 28.97
US$ 21.32
US$ 21.82
US$ 28.17
